TFF Pharmaceuticals
TFF Pharmaceuticals is a dry-powder Inhalation for Respiratory Therapies founded in 2018.
2
Funding Rounds
$22.2m
Money raised
Overview
TFF Pharmaceuticals is a dry-powder Inhalation for Respiratory Therapies founded in 2018.
- Website:
- Business model: B2B
Funding
Funding series
Funding Series Analysis
The company TFF Pharmaceuticals has raised a total of $22.2m in funding over 2 rounds.
Key Insights:
- TFF Pharmaceuticals Series A round, May 2019: $8.2m
- TFF Pharmaceuticals Series A round, April 2018: $14m
TFF Pharmaceuticals Series A round, May 2019
$8.2m
TFF Pharmaceuticals Series A round, April 2018
$14m
Industries
TFF Pharmaceuticals is active in the following industries: